Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/51368, first published .
Design and Rationale of Prolonged Nightly Fasting for Multiple Myeloma Prevention (PROFAST): Protocol for a Randomized Controlled Pilot Trial

Design and Rationale of Prolonged Nightly Fasting for Multiple Myeloma Prevention (PROFAST): Protocol for a Randomized Controlled Pilot Trial

Design and Rationale of Prolonged Nightly Fasting for Multiple Myeloma Prevention (PROFAST): Protocol for a Randomized Controlled Pilot Trial

David J Lee   1, 2, 3 , MD, MPH, MMSc ;   Elizabeth K O'Donnell   2, 3, 4 , MD ;   Noopur Raje   1, 3 , MD ;   Cristina Panaroni   1, 3 , PhD ;   Robert Redd   5 , MS ;   Jennifer Ligibel   2, 3 , MD ;   Dorothy D Sears   6 , PhD ;   Omar Nadeem   2, 3, 4 , MD ;   Irene M Ghobrial   2, 3, 4 , MD ;   Catherine R Marinac   2, 3, 4 , PhD

1 Department of Medicine, Massachusetts General Hospital, Boston, MA, United States

2 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States

3 Harvard Medical School, Boston, MA, United States

4 Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA, United States

5 Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, United States

6 College of Health Solutions, Arizona State University, Phoenix, AZ, United States

Corresponding Author:

  • David J Lee, MD, MPH, MMSc
  • Department of Medicine
  • Massachusetts General Hospital
  • 55 Fruit St.
  • Boston, MA, 02114
  • United States
  • Phone: 1 6177242450
  • Fax: 1 6177247441
  • Email: DJLee@mgh.harvard.edu